黄素对非酒精性脂肪肝疾病的影响:一项科学计量学研究

Xiankuan Li1, Weisan Chen2, Jiali Ren2

  • 1School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; State Key Lab of New Ceramics and Fine Processing, School of Materials Science and Engineering, Tsinghua University, Beijing 100084, China; Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine, Tianjin 301617, China.

概括

黄素在治疗非酒精性脂肪性肝病 (NAFLD) 中表现有前途,通过减少炎症和改善胰岛素耐药性. 然而,它的有效性受到低生物利用度的限制,需要对增强的输送方法进行进一步的研究.

相关概念视频